Foreign CEOs now run half of life science companies on the Copenhagen stock exchange: "We are on our way to becoming the international elite"
The number of foreign CEOs af listed Danish life science companies has more than doubled in the last three years. Industry players call it a positive development, which mirrors an industry that is growing quickly - but they are still looking for more Danish talent
Over the past ten years, Orphazyme has grown into one of Danish biotech's biggest successes, and it therefore generated a lot of attention when the company announced that founder and CEO Anders Hinsby was stepping down, to be replaced by Kim Stratton from Shire.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
